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1. Introduction 
Current models of the active center of ribosomal 
peptidyl transferase generally invoke a P-subsite which 
binds the CCA terminus of peptidyl-tRNA and an A- 
subsite which binds at least part of the CCA terminus 
of AA-tRNA [I] . Since the CCA sequence occurs at 
the 3’-terminus of all tRNAs, it is at least indirectly in- 
volved in peptide bond formation. It therefore follows 
that the elucidation of the role of these sequence in 
binding to peptidyl transferase sites is a necessary step 
toward understanding the nature of the peptide bond 
formation center. 
One approach which has met with some success in 
investigating the involvement of the CCA termini of 
peptidyl- and AA-tRNAs in the peptidyl transferase 
reaction has involved the use of N-acylaminoacyl or 
aminoacyl terminal fragments of tRNA as substrate 
analogs of the parent molecules [2-l 61. Compounds 
of this type (e.g., AA-oligonucleotides or AA-nucle- 
osides) can be prepared by chemical synthesis or by 
enzymatic degradation of the corresponding tRNA de- 
rivatives. Despite its complexity, chemical synthesis of 
substrate analogs for peptidyl transferase offers the im- 
portant advantage that unnatural compounds, i.e., non- 
CCA-AA sequences, can be synthesized. The study of 
such compounds in ribosomal systems can thus enable 
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one to define several portions of the acceptor or donor 
substrate molecule which are important for interactions 
with the A- or P-subsites. 
Four new AA-dinucleoside phosphates, CAPhe, 
CdAPhe. CdAGly and CUPhe, were synthesized and 
examined with respect to their ability to serve as accep- 
tor substrate analogs of AAtRNA in the peptidyl trans- 
ferase reaction. CAPhe and CdAPhe were found to be 
far more potent acceptors than puromycin while CdAGly 
and CUPhe were found to be inactive. Results are dis- 
cussed with respect to the role of the 2’-hydroxy group 
of the terminal aaenosine unit, the amino acid side 
chain, and the base sequence in the binding of the CCa 
terminus of AA-tRNA to the A subsite. 
2. Materials and methods 
Bacterial ribosomes were prepared from late log E. 
coli MRE 600 (RNAase 13 cells (General Biochemicals) 
as previously described [ 171. The ribosomes were 
washed three times by centrifugation in the presence 
of high NH4 Cl concentrations [ 183 and showed no re- 
quirement for pre-activation [ 191 to give maximum 
activity in the assay systems used here. 
AC- [ l4 C] Phe-tRNA was prepared as before [ 171 
and had a specific radioactivity of 220 000 cpm/mg 
tRNA which corresponds to a charging efficiency of 
0.4 nmole [‘“Cl penylalanine/mg tRNA. 
The chemical synthesis of the 2’(3’)-O-aminoacyldi- 
nucleoside phosphates used in this study is described 
elsewhere [20,2 1 ] . 
Peptidyl transferase activity was measured essential- 
ly as described by Rychlik et al. [8]. Details of the re- 
action conditions and contents are given in the legend 
to fig. 1. 
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Fig. 1.2’(3’)-0-Aminoacyldinucleoside phosphate dependent release of the IV-acetyl-[ 14C] phenylalanyl residue from N-acetyl -[ 14C] 
phenylalanyl-tRNA in the peptidyl transferase reaction. Each reaction mixture contained in 0.15 ml: 50 mM Tris-HCl (pH 7.4); 
100 mM NH4Cl; 10 mM MgC12; 3.2Azbo units of ribosomes; 10 clg poly(U); 0.15.4 260 units of AC-[ 14C] Phe-tRNA (1350 cpm). 
The reaction was initiated by the addition of the acceptor compounds at the concentrations indicated. Following incubation at 37°C 
for 30 min, the reaction was terminated by the addition of 2.0 ml of 2.5% CCl3COOH WA) at 4°C. After 15 min at 4”C, the 
entire reaction mixture was filtered through a HAWP-Millipore membrane which was then washed with three 2.0 ml portions of 
cold 2.5% TCA. After the membranes were dried, the radioactivity was determined in a 4.5 g/100 mg dimethylPOPOP/l liter toluene 
scintillation mixture. The amount of AC-[ 14C] Phe residue transferred from AC-[ 14C] Phe-tRNA to the acceptor was determined as 
the difference between radioactivity retained on the filter after incubation without acceptor and that retained after incubation 
which an acceptor. It was expressed as the percentage of the radioactivity of AC-[ 14C] Phe-tRNA added to the experimental mix- 
ture. 
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Fig. 2. Time course of N-acetyl-[ 14C] phenylalanine transfer 
from N-acetyl-[ “Cl phenylallnyl-tRNA to 2’(3’)-O-aminoacyldi- 
nucleoside phosphates. The percent of N-acetyl-[ 14C] phenyl- 
alanine released during the peptidyl transferase reaction from 
the donor molecule was determines as described in fig. 1. Ac- 
ceptor molecule concentration was the same for all reactions, 
1.0 X l@ M., 
3..Re~ults and discussion 
Of the four 2’(3’)0aminoacyldinucleoside phos- 
phates tested for acceptor activity (fig. I), CAPhe, the 
3’-terminus of Phe-tRNA, was the best acceptor of the 
Ac-Phe residue. Relative to puromycin, a standard ac- 
ceptor substrate, CAPhe demonstrated very appreciable 
acceptor activity at low acceptor concentrations (lo-* 
to 10e6 M) giving 50% release at 2.5 X lo-’ M while 
puromycin showed acceptor activity comparable to 
CAPhe. As can be seen in fig. 2, CAPhe also has a high- 
er rate of reaction than puromycin. The remarkable in- 
crease of acceptor activity of CAPhe compared to APhe 
clearly indicates that A-subsite possesses a locus for the 
penultimate Cp residue as we have previously suggested 
[4] . This is in agreement with the recent report [ 161 
that the S’-cytidylyl derivative of puromycin shows 7 
times greater activity than puromyncin in the inhibition 
of de novo polypeptide synthesis in a cell-free system 
from rabbit reticulocytes. 
Although dAPhe has been previously found to be 
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essentially inactive as an acceptor [8] , its 5’-cytidylyl 
derivative, CdAPhe, displays both acceptor activity 
(50% release at 5.0 X 1 O-’ M) and rate of reaction ap- 
proaching that of CAPhe (figs. 1 and 2). Also, as re- 
ported earlier, two modified derivatives of APhe having 
a substituent at the 2’-OH, namely 2’, 3’-O-bis-L-phenyl- 
alanyladenosine [lo] and 2’-O-methyl-3’-O-L-phenyl- 
alanyldensine [14] , are good acceptors. Therefore, it 
seems reasonable to assume that the 2’-oxygen plays 
an auxiliary role in the binding of the acceptor substrate 
to the A-subsite but the free hydroxyl group is not es- 
sential. 
CdAPhe and CdAGly possess identical nucleotide se- 
quences, yet they demonstrate vastly different activi- 
ties (fig. 1). Whereas CdAPhe had activity between that 
of CAPhe and puromycin, CdAGly showed slight activ- 
ity and only at high acceptor concentrations (( 10% re- 
lease at lo4 M). While CdAGly possesses the Cp resi- 
due, it lacks both an aminoacyl side chain and the 2’- 
OH group which cause the glycine residue to be less 
firmly attached to the A-subsite and thus less active as 
an acceptor. 
In order to explain the high activity of AA-deriva- 
tives containing aromatic amino acids, we have postu- 
lated that the ribosomal A-subsite contains a hydro- 
phobic locus whose interaction with the aromatic ring 
of the amino acid residue would be strongly enhanced 
by the n-electron system [12]. Alternatively, but not 
excluding the first hypothesis, the sandwhich-like struc- 
ture resulting from ring stacking in CAPhe can be con- 
sidered as an active form of the molecule which is rec- 
ognized by the A-subsite. As shown from the crystal- 
lographic study of puromycin by Sundaralingam and 
Arora [22] , purine and tyrosine rings can form alter- 
nating stacks. It is conceivable that this stacking inter- 
action could act as an extension of the stacking of the 
A- and C-residues of the 3’-terminus of tRNA. This or- 
dered structure, with the properly oriented a-amino 
group, would be far more probable with aromatic amino 
acids, thus possibly explaining the high affinity of sub- 
strates containing aromatic amino acids such as APhe 
and CAPhe for the A-subsite. Warshaw and Cantor [23] 
have pointed out that in mixed deoxy- and ribodinucle- 
oside phosphates it is the conformation of the 3’-linked 
monomer that determines the overall geometry of the 
dimer. Thus, a sandwich-like structure as referred to 
above for CAPhe is also feasible for CdAPhe. 
The last compound tested, CUPhe, which contains 
the benzyl residue of phenylalanine, 2’-OH and penul- 
timate Cp residue, was inactive (fig. 1) indicating that 
replacement of adenosine by uridine in the ultimate 
position resulted in the loss of acceptor activity [8]. 
Apparently the uridine residue in CUPhe cannot bind 
to the adenosine locus of the A-subsite at all and CUPhe, 
although it contains other binding points, cannot be 
accommodated by the A-subsite. 
From these results and the above discussion we con- 
clude that at least one of two particular portions of 
the acceptor molecule (amino acid side chain or 2’-OH) 
appear to be necessary for acceptor activity. It is ex- 
pected that the biochemical evaluation of other AA- 
and Ac-AA-oligonucleotide derivatives, currently of 
peptidyl transferase sites. 
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